First quarter of 2022: ASA continues to grow

08 April 2022 - Corporate -

The figures leave no room for doubt: for ASA, the first quarter of 2022, compared to the same period of 2021, continues to show growth, both in terms of turnover and in terms of the devices produced.

This is the result of a well thought-out commercial strategy aimed at consolidating existing businesses while developing high-potential markets.

“We have been achieving these objectives thanks to a solid policy of working alongside our long-term partners, to whom we offer continuous support in planning activities and new functional products and technologies to gain a leading role in the market. Instead, in countries we are approaching for the first time, we have been focusing on supporting daily information and training activities to promote the dissemination of our technologies and therapies”.

And during the first three months of the year, these therapies confirmed their growth and worldwide distribution.
The complex global socio-economic situation, together with the post-pandemic implications, has had a tangible impact on the company, but does not limit development projects.

“Pressure on prices, difficult-to-manage procurement schedules for components and packaging and significant increases in energy and transport costs are some of the critical issues we have to deal with on a daily basis. Unfortunately, we do not expect the situation to become stable any time soon, so we remain flexible and responsive to individual markets with very different commercial and training needs, but all equally relevant. Our distributors are aware of the situation and they are not quitting; they know that business is not only about the product: relationships and common visions are essential to win”,

concludes Federico Castellani - ASA Sales Manager.

You might also be interested in ...

See all articles

ASAlaser Indonesia - IGNITE
News - 31/03/2026
The collaboration between ASAlaser and GEA Medical Indonesia marks a strategic step in the expansion of advanced laser therapy within a rapidly growing healthcare market.
ASAlaser LATAM Sales Meeting 2026
News - 30/03/2026
ASA recently organised the Sales Meeting for the LATAM area at the NH Collection hotel in Barranquilla, assembling distributors from throughout Latin America. The event represented an important...
M-Hi All Terrain
News - 12/03/2025
M-Hi All Terrain redefines the standards of MLS® Laser Therapy, combining portability, resistance and operational autonomy to offer effective treatments anywhere.
Post-burn lesion on the lateral surface of the lower limb
Blog - 24/06/2026
Severe burns are one of the most complex conditions to address in clinical and rehabilitation settings. Beyond the initial tissue damage, the recovery process can be long and challenging,...
MLS Laser Therapy anti-inflammatory effect
Blog - 18/06/2026
Photobiomodulation (PBMT) is an evolving field of research, with growing interest towards its biological effects on tissues, particularly in modulating inflammatory processes. A recent experimental...
Shoulder laser treatment with HIRO TT
Blog - 08/06/2026
Photobiomodulation (PBMT) at 1064 nm is increasingly being studied in musculoskeletal disorders, particularly shoulder tendinopathies. A recent study published in the Journal of Clinical Medicine (...